title: BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy.
authors.affiliation: Rheumatology Department, Royal Derby Hospital, Derby DE22 3NE, UK. chris.deighton@derbyhospitals.nhs.uk
authors.forename: Chris
authors.initials: C
authors.lastname: Deighton
authors.forename: Kimme
authors.initials: K
authors.lastname: Hyrich
authors.forename: Tina
authors.initials: T
authors.lastname: Ding
authors.forename: Jo
authors.initials: J
authors.lastname: Ledingham
authors.forename: Mark
authors.initials: M
authors.lastname: Lunt
authors.forename: Raashid
authors.initials: R
authors.lastname: Luqmani
authors.forename: Patrick
authors.initials: P
authors.lastname: Kiely
authors.forename: Marwan
authors.initials: M
authors.lastname: Bukhari
authors.forename: Rikki
authors.initials: R
authors.lastname: Abernethy
authors.forename: Andrew
authors.initials: A
authors.lastname: Ostor
authors.forename: Ailsa
authors.initials: A
authors.lastname: Bosworth
authors.forename: Kate
authors.initials: K
authors.lastname: Gadsby
authors.forename: Frank
authors.initials: F
authors.lastname: McKenna
authors.forename: Diana
authors.initials: D
authors.lastname: Finney
authors.forename: Josh
authors.initials: J
authors.lastname: Dixey
mesh_terms: D000328:Adult; D018501:Antirheumatic Agents / Q000191:economics / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000191:economics; D001691:Biological Therapy / Q000191:economics / Q000379:methods; D004608:Eligibility Determination / Q000191:economics*; D006077:Government Agencies; D017408:Guidelines as Topic; D006801:Humans; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors* / Q000191:economics / Q000627:therapeutic use; D006113:United Kingdom
chemical_list: D018501:Antirheumatic Agents; D014409:Tumor Necrosis Factor-alpha